Elea shareholders buy Cellera Farma, target Brazil expansion
Argentine pharmaceutical group acquires 90% stake in Brazilian company; Omilton Visconde Junior retains a 10% stake and remains CEO 05/20/2026 Shareholders of Elea, one of Argentina’s largest pharmaceutical companies, finalized this week the acquisition of Cellera Farma, Brazil’s youngest domestically controlled drugmaker, marking their entry into the Brazilian market and the start […]
